Barbara Brandt

Barbara Brandt possesses extensive experience in project management and research within rare disease clinical outcome assessments. Currently serving as a Senior Project Manager at the Critical Path Institute's Rare Disease Clinical Outcome Assessment Consortium, Barbara facilitates multi-stakeholder collaboration to develop methodologies for meaningful outcomes in treatment trials. Additionally, Barbara is a member of the Board of Directors for the Lucky Fin Project, a global support network for children with upper limb differences. Previous roles include Social Media Director at KIDspace Studios and various positions at RWS and Corporate Translations, where Barbara specialized in survey research and linguistic validation. Barbara holds an M.A. in Survey Research and a B.A. in Linguistics and Psychology, both from the University of Connecticut.